Abstract
Safety Profile Characterization of Evobrutinib in Over 1000 Patients from Phase II Clinical Trials in Multiple Sclerosis, Rheumatoid Arthritis and Systemic Lupus Erythematosus (S14.007)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have